Author

Yuru Li

Observed name: Y. Li

Institutions: Capital Medical University, Beijing Shijitan Hospital

Observed institutions: Capital Medical University, Sun Yat-sen University Cancer Center, Beijing Shijitan Hospital, Xiangya Hospital Central South University

OpenAlex ID: A5115044847

A Comprehensive Review of Vitamin C for Cancer Therapy: Anti-Tumor Mechanisms and Nano-Formulation Strategies

2026 · Pinxu Ge, Xiaomei Tao, et al. · International Journal of Nanomedicine · 4

249P The intratumoral metabolic characterization and potential mechanisms in pancreatic ductal adenocarcinoma

2024 · D. Luo, Y. Li, et al. · Annals of Oncology · 1

42P Safety, tolerability, pharmacokinetics, and antitumor activity of FDA022-BB05 in patients with advanced/metastatic solid tumors: A multicenter, open-label, first-in-human, phase I/Ib study

2024 · X. Wang, Y. Li, et al. · Annals of Oncology · 1

Exploring potential mechanisms of triclosan and triclocarban in colorectal cancer development: an integrative study combining network toxicology, molecular docking, molecular dynamics simulation, machine learning, and experimental validation

2026 · Jinxiu Qu, Yuru Li, et al. · Toxicology Research

336MO A phase II single-arm, open-label trial of pamiparib in metastatic castration-resistant prostate cancer (mCRPC) patients with deleterious germline or somatic BRCA1/2 alterations or homologous recombination deficiency (HRD): Interim analysis of efficacy and safety results

2024 · D. Zhao, J. Zhao, et al. · Annals of Oncology

Works count: 5

Citation count: 6

H-index: 1

I10-index: